Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
37.28 USD | -1.23% | -5.57% | -6.03% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.03% | 2.49B | |
+39.89% | 54.04B | |
+43.57% | 41.96B | |
-0.98% | 41.92B | |
-7.59% | 28.35B | |
+12.78% | 26.35B | |
-21.96% | 19B | |
+7.52% | 13B | |
+28.69% | 12.28B | |
+25.55% | 12.19B |
- Stock Market
- Equities
- CLDX Stock
- News Celldex Therapeutics, Inc.
- Celldex Therapeutics Says Prurigo Nodularis Phase 1b Study of Barzolvolimab Showed 'Durable Reductions in Itch'